Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Updated efficacy and tolerability of durvalumab in locally advanced or metastatic urothelial carcinoma (UC). Hahn, N. M., Powles, T., Massard, C., Arkenau, H., Friedlander, T. W., Holmes, C. J., Lee, J., Ong, M., Sridhar, S. S., Vogelzang, N. J., Fishman, M. N., Zhang, J., Srinivas, S., Parikh, J., Antal, J., Jin, X., Ben, Y., Gupta, A., O'Donnell, P. H. AMER SOC CLINICAL ONCOLOGY. 2017
View details for DOI 10.1200/JCO.2017.35.15_suppl.4525
View details for Web of Science ID 000411931702025